CalciMedica, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$23.1M | -$24.2M | -$38.1M | -$14.2M | -$35.9M |
| Operating expenses | $23.1M | $24.2M | $38.1M | $14.2M | $35.9M |
| Cash from operations | -$21.2M | -$21.1M | -$25.7M | -$11.8M | -$31.5M |
| Capital expenditure | $28,000 | $8,000 | $78,000 | $4,000 | $488,000 |
| Free cash flow | -$21.2M | -$21.2M | -$25.8M | -$11.8M | -$32.0M |
| Impairments | — | — | $0 | $1.6M | $0 |
| Total assets | $13.6M | $19.8M | $12.2M | $3.3M | $69.1M |
| Total liabilities | $20.2M | $5.4M | $4.0M | $12.6M | $4.1M |
Shares outstanding 15.8M · Free float 83.9%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.